This is the authors' abstract. We don't add key points for this paper.
The efficacy of Aprotinin as prophylactic treatment of Covid-19 was studied in the hamster model of SARS-CoV-2 and in the health care personnel working with Covid-19 patients in hospital. High efficacy of Aprotinin in pre- and post-exposure prophylaxis of SARS-CoV-2 was demonstrated.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ivashchenko et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: